Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

896

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2032

Conditions
Colon Cancer
Interventions
PROCEDURE

SMA lymph node dissection

The lymph node dissection boundary is on the left side of the superior mesenteric artery (SMA)

PROCEDURE

SMV lymph node dissection

The lymph node dissection boundary is on the left side of the superior mesenteric vein (SMV)

Trial Locations (1)

310022

Zhejiang cancer hospital, Hangzhou

All Listed Sponsors
collaborator

Jiangxi Provincial Cancer Hospital

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

Liaoning Cancer Hospital & Institute

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

Shanxi Province Cancer Hospital

OTHER

collaborator

The First Affiliated Hospital of Shanxi Medical University

OTHER

collaborator

Shaoxing People's Hospital

OTHER

collaborator

Shaoxing Second Hospital

OTHER

collaborator

Ningbo No. 1 Hospital

OTHER

collaborator

Ningbo No.2 Hospital

OTHER

collaborator

Jinhua Central Hospital

OTHER

collaborator

Affiliated Hospital of Jiaxing University

OTHER

collaborator

The First People's Hospital of Huzhou

OTHER

collaborator

The Central Hospital of Lishui City

OTHER

collaborator

Lishui Country People's Hospital

OTHER

collaborator

Zhejiang University

OTHER

collaborator

Yuyao People's Hospital

OTHER

collaborator

The Third Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Cancer Hospital of Guangxi Medical University

OTHER

collaborator

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

collaborator

Ruijin Hospital

OTHER

collaborator

Second Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

collaborator

Shanghai Cancer Hospital, China

OTHER

collaborator

The Affiliated Tumor Hospital of Harbin Medical University

UNKNOWN

collaborator

Shanghai 10th People's Hospital

OTHER

collaborator

The Second Affiliated Hospital of Harbin Medical University

OTHER

collaborator

Xiangshan No.1 People' s Hospital

UNKNOWN

collaborator

Zhejiang Province People's Hospital

UNKNOWN

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

Sun Yat-sen University Cancer Hosptial

UNKNOWN

lead

Haixing Ju, MD

OTHER